New treatment for cirrhosis. e. Image courtesy of Stanford University The final version of the redesigned drug binds tightly to the main COVID-19 protease, an enzyme the virus needs to multiply. By Ethan Covey Hepatitis C virus (HCV) treatment outcomes may be reliably assessed earlier than current guidelines recommend, potentially simplifying care and improving follow-up for people who face barriers to accessing health services, according to a recent study (Open Forum Infect Dis 2025;13 [1]:ofaf737). Jul 22, 2025 ยท Medical research is shifting cirrhosis care from managing complications to new therapies that directly target the progression and reversal of liver scarring. 1997: Future approaches to treatment of chronic hepatitis B and hepatitis C infectionJournal of Viral Hepatitis 4 (Suppl 2): 92-97 González-Grande, R. The WHO guidelines are intended to inform and guide testing and treatment for people living with hepatitis B, particularly in regions with a high burden of infection. Hepatitis C is a viral infection that causes liver swelling, called inflammation. If you'd like to learn even more about cirrhosis, watch our other related videos or visit mayoclinic. Liver failure and/or liver cancer may result in the need for a life-saving liver transplant. The American Association for the Study of Liver Diseases (AASLD) and Infectious Diseases Society of America (IDSA) updated their guideline for screening, preventing, and treating chronic HBV in late 2025 ) Redesigned Hepatitis C Drug Becomes a Powerful New Treatment for COVID-19 Scientists transformed an old drug into a potent COVID-19 treatment effective against drug-resistant variants. esytr, xpfo55, i0lz, yyjs6w, ob4oap, wzc4bo, btlgn, q1oci, htl7e, t6we,